Search for: "Novartis LLC"
Results 161 - 180
of 183
Sort by Relevance
|
Sort by Date
13 Jul 2009, 6:45 am
(Afro-IP) Spain Trade mark cancellation and damages: a matter of (bad) faith (Class 46) United Kingdom EWHC (Pat): No ruling on hypothetical issue: MMI Research Ltd v Cellxion Ltd (IPKat) EWHC (Pat): EP 258 valid in Netherlands but not UK: Novartis AG and Cibavision AG v Johnson & Johnson Medical Ltd & Ors (PatLit) EWHC: Trial judge says ‘Boileau’ to patent licence; appeal court agrees: Oxonica Energy Ltd v Neuftec Ltd (IPKat)… [read post]
21 May 2009, 1:42 am
The criminal prosecution, which carries a maximum prison sentence of seven years, relates to Novartis' 2006 takeover of Neutec, according to court documents. [read post]
14 May 2009, 1:45 pm
The deals included Novartis AG's (NVS) acquisition of Eon Labs in 2005, Electronic Arts Inc. [read post]
7 May 2009, 6:08 am
Novartis Pharmaceuticals Corp., 252 F.3d 986, 990 (8th Cir. 2001); Hans v. [read post]
1 May 2009, 9:00 am
Products Alimta (Pemetrexed) – US: Eli Lilly files patent infringement suit over Barr’s ANDA to manufacture generic Alimta (Patent Docs) Arthrotech (Diclofenac/Misoprostol) – US: Pfizer files patent infringement suit against Teva over generic Arthrotech ANDA (Patent Docs) Enablex (Darifenacin hydrobromide) – US: Watson files ANDA to market generic Enablex prior to expiration of Novartis’ patent (GenericsWeb) Flanax (Naproxen)… [read post]
27 Feb 2009, 7:00 am
(BLOG@IP::JUR) Changes to EPO fee structure, 1 April 2009 (BLOG@IP::JUR) (Patent Baristas) Changes of patent culture (BLOG@IP::JUR) MARQUES 3rd annual review of community design case law (Managing Intellectual Property) PDO amendment – Chabichou du Poitou (Class 46) France French trade marks database opens publicly on 3 April 2009 (Class 46) Union pour un Mouvement Populaire to compensate MGMT for use of song ‘Kids’ at party rallies without seeking permission… [read post]
27 Feb 2009, 5:00 am
USA, Inc (Orange Book Blog) (FDA Law Blog) (Patent Baristas) (Law360) (Patent Docs) (Patent Prospector) (Patently-O) (GenericsWeb) (Hal Wegner) Famvir (Famciclovir) – US: Teva loses bid to toss Novartis wilful infringement claims over Famvir (Law360) Fentora (Fentanyl) – US: Barr alleges Cima and Cephalon’s patent suit just a delay tactic (Law360) Integrilin (Eptifibatide) – US: Schering alleges patent infringement following Teva’s Para IV… [read post]
12 Sep 2008, 2:33 pm
: (IP finance), MARQUES international advertising portal goes live: (Class 46) Global - Patents Using patent landscaping analytics to improve the quality of M & A decisions: a review of Cox Enterprises’ $300M purchase of Adify: (IP Asset Maximiser Blog), Universities reap royalty rewards; investors ignore IP at their peril: (IAM), Top IP-owning nations claim faster patent processing; near harmonisation deal: (Intellectual Property Watch), Bosch, Xerox and Dupont sign up… [read post]
25 Aug 2008, 4:10 am
Novartis Pharmaceuticals Corp., Benitec Australia, Ltd. v. [read post]
23 Aug 2008, 1:23 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
21 Aug 2008, 9:43 pm
More on Prasco LLC v. [read post]
25 Jul 2008, 7:04 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
26 Jun 2008, 6:31 pm
Dow Agrosciences LLC, 544 U.S. 431 (2005):In undertaking a pre-emption analysis. . ., a court should bear in mind the concept of equivalence. [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro… [read post]
4 Apr 2008, 1:00 am
: (creativecommons.org), Neil Netanel’s copyright paradox: (Patry Copyright Blog), Isn’t it ironic: TechCrunch blames the music industry for the dangerous ideas of Lessig and the free culture movement: (IPcentral.com) CFP: First interdisciplinary research workshop on free culture: (creativecommons.org), Of limitations, exceptions and verse (WIPO copyright committee): (KEI) Pharma & Biotech Pharma & Biotech - General StemCellPatents.com… [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners: PharmaStem … [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA is objecting… [read post]
11 Jan 2008, 9:00 am
., GlaxoSmithKline and Mitsubishi Chemical Corp. file patent infringement lawsuit to stop Barr Laboratories from producing a generic version of the anti-blood clotting drug: (IP Law360), Biaxin (Clarithromycin) - Court holds in Abbott Labs v Sandoz that use of Markush group language in the specification does not necessarily limit construction of claim terms: (Chicago IP Litigation),Coreg / Dilatrend / Eucardic (Carvedilol) - Teva Pharmaceutical Industries… [read post]
14 Dec 2007, 1:00 am
Bard Inc.'s patent on a type of prosthetic blood vessel graft, company to pay damages of $185 million: (IPLaw360), Depomed secures summary judgment against Ivax in its patent dispute regarding its AcuForm controlled-release drug delivery technology: (IPLaw360),Dell and Motion Computing hit with patent infringement suit by Typhoon Touch: (IPBiz), EBay vows fight over final judgment in patent suit against MercExchange: (IPLaw360), … [read post]
